US$ 22.78
glp-1 producers 2025’s Breakthrough Obesity Treatments: Top Companies & Innovations Market Overview: GLP-1 Agonists and
Description
6 Semaglutide produced significantly greater weight loss (an 1112 kg difference versus placebo) and larger improvements in pain (Western Ontario and McMaster Universities Arthritis Index [WOMAC] score: 41.7 versus 27.5)

Patients who have switched to other glucose-lowering medicines during the shortage but still have a valid GLP-1 therapy prescription such as Ozempic should consult their doctor for guidance

Sun Z, Tong G, Kim TH, Ma N, Niu G, Cao F, Chen X

Source: Jastreboff et al., NEJM (2022)

This difference is enormous

This is not disproportionate
